Gene · 8324
Papers1,967
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,967
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Altered binding affinity of SIX1-Q177R correlates with enhanced WNT5A and WNT pathway effector expression in Wilms tumor. | Dis Model Mech | 2023 | 37815464 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling reveals immune and stromal cell heterogeneity in primary Sjögren's syndrome. | iScience | 2023 | 37810210 | PubTator, text mining | PubMed |
| Expression pattern, prognostic value and potential microRNA silencing of FZD8 in breast cancer. | Oncol Lett | 2023 | 37809047 | PubTator, text mining | PubMed |
| FZD7: A potential biomarker for endometriosis. | Medicine (Baltimore) | 2023 | 37800830 | PubTator, text mining | PubMed |
| GPC3 gene expression and allelic discrimination of FZD7 gene in Egyptian patients with hepatocellular carcinoma. | Rep Pract Oncol Radiother | 2023 | 37795234 | PubTator, text mining | PubMed |
| Role of non-canonical post-translational modifications in gastrointestinal tumors. | Cancer Cell Int | 2023 | 37777749 | PubTator, text mining | PubMed |
| ADAM11 a novel regulator of Wnt and BMP4 signaling in neural crest and cancer. | Front Cell Dev Biol | 2023 | 37766964 | PubTator, text mining | PubMed |
| WNT pathway in focal cortical dysplasia compared to perilesional nonlesional tissue in refractory epilepsies. | BMC Neurol | 2023 | 37749503 | PubTator, text mining | PubMed |
| Nectin-3 and shed forms of CSPG4 can serve as epithelial cell receptors for Clostridioides difficile TcdB. | mBio | 2023 | 37747247 | PubTator, text mining | PubMed |
| An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer. | BMC Cancer | 2023 | 37723477 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts influence Wnt/PCP signaling in gastric cancer cells by cytoneme-based dissemination of ROR2. | Proc Natl Acad Sci U S A | 2023 | 37722040 | PubTator, text mining | PubMed |
| Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation. | J Exp Clin Cancer Res | 2023 | 37705041 | PubTator, text mining | PubMed |
| Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer. | Front Immunol | 2023 | 37691919 | PubTator, text mining | PubMed |
| TMT-Based Quantitative Proteomics Analysis Reveals Differentially Expressed Proteins between Different Sources of hMSCs. | Int J Mol Sci | 2023 | 37686351 | PubTator, text mining | PubMed |
| Single-Cell Transcriptional Landscape Reveals the Regulatory Network and Its Heterogeneity of Renal Mitochondrial Damages in Diabetic Kidney Disease. | Int J Mol Sci | 2023 | 37686311 | PubTator, text mining | PubMed |
| Comprehensive Strategy for Identifying Extracellular Vesicle Surface Proteins as Biomarkers for Non-Alcoholic Fatty Liver Disease. | Int J Mol Sci | 2023 | 37686134 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers. | Int J Mol Sci | 2023 | 37685983 | PubTator, text mining | PubMed |
| MultiGML: Multimodal graph machine learning for prediction of adverse drug events. | Heliyon | 2023 | 37681175 | PubTator, text mining | PubMed |
| Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma. | Front Immunol | 2023 | 37680641 | PubTator, text mining | PubMed |
| Structure-Based Ligand Discovery Targeting the Transmembrane Domain of Frizzled Receptor FZD7. | J Med Chem | 2023 | 37669317 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8324/papers?page=8